← Back to Screener
Boston Scientific Corp. (BSX)
Price$60.99
Favorite Metrics
Price vs S&P 500 (26W)-42.66%
Price vs S&P 500 (4W)-20.43%
Market Capitalization$91.89B
P/E Ratio (Annual)31.71x
All Metrics
P/CF (Annual)20.27x
Book Value / Share (Quarterly)$16.34
P/TBV (Annual)8.21x
Revenue Growth (3Y)16.54%
Cash Flow / Share (Quarterly)$2.47
Price vs S&P 500 (YTD)-39.97%
Gross Margin (TTM)69.01%
Net Profit Margin (TTM)14.44%
EPS (TTM)$1.94
10-Day Avg Trading Volume13.66M
EPS Excl Extra (TTM)$1.94
Revenue Growth (5Y)15.16%
EPS (Annual)$1.94
Dividend / Share (Annual)$0.00
ROI (Annual)8.12%
Gross Margin (Annual)69.01%
Net Profit Margin (5Y Avg)10.19%
Cash / Share (Quarterly)$1.32
P/E Basic Excl Extra (TTM)31.70x
Revenue Growth QoQ (YoY)15.90%
P/E Normalized (Annual)31.71x
ROA (Last FY)6.64%
Revenue Growth TTM (YoY)19.88%
EBITD / Share (TTM)$3.11
ROE (5Y Avg)7.79%
Operating Margin (TTM)18.00%
Cash Flow / Share (Annual)$2.47
P/B Ratio3.79x
P/B Ratio (Quarterly)5.83x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)5.05x
Net Interest Coverage (TTM)21.27x
ROA (TTM)6.90%
EPS Growth QoQ (YoY)18.27%
EV / EBITDA (TTM)21.83x
EPS Incl Extra (Annual)$1.94
Current Ratio (Annual)1.62x
Quick Ratio (Quarterly)1.02x
3-Month Avg Trading Volume14.50M
52-Week Price Return-35.88%
EV / Free Cash Flow (Annual)27.71x
P/E Incl Extra (TTM)31.70x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$11.61
P/S Ratio (Annual)4.58x
Asset Turnover (Annual)0.46x
52-Week High$109.50
Operating Margin (5Y Avg)14.56%
EPS Excl Extra (Annual)$1.94
CapEx CAGR (5Y)10.91%
Tangible BV CAGR (5Y)12.84%
26-Week Price Return-35.77%
Quick Ratio (Annual)1.02x
13-Week Price Return-32.26%
Total Debt / Equity (Annual)0.47x
Current Ratio (Quarterly)1.62x
Enterprise Value$101,361.37
Revenue / Share Growth (5Y)13.93%
Asset Turnover (TTM)0.48x
Book Value / Share Growth (5Y)8.60%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.16x
Pretax Margin (Annual)16.86%
Cash / Share (Annual)$1.32
3-Month Return Std Dev46.96%
Gross Margin (5Y Avg)69.08%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)44.06%
EBITDA Interim CAGR (5Y)32.74%
ROE (Last FY)11.96%
Net Interest Coverage (Annual)10.38x
EPS Basic Excl Extra (Annual)$1.94
P/FCF (TTM)25.12x
Receivables Turnover (TTM)7.32x
EV / Free Cash Flow (TTM)27.71x
Total Debt / Equity (Quarterly)0.47x
EPS Incl Extra (TTM)$1.94
Receivables Turnover (Annual)7.32x
ROI (TTM)8.39%
P/S Ratio (TTM)4.58x
Pretax Margin (5Y Avg)12.50%
Revenue / Share (Annual)$13.43
Tangible BV / Share (Annual)$11.61
Forward P/E17.67x
Free OCF CAGR (5Y)29.98%
Price vs S&P 500 (52W)-70.51%
P/E Ratio (TTM)31.70x
EPS Growth TTM (YoY)55.57%
Year-to-Date Return-36.04%
5-Day Price Return-4.43%
EPS Normalized (Annual)$1.94
ROA (5Y Avg)4.25%
Net Profit Margin (Annual)14.44%
Month-to-Date Return-2.80%
Cash Flow / Share (TTM)$1.63
EBITD / Share (Annual)$2.98
EPS Growth (3Y)58.74%
Operating Margin (Annual)17.87%
LT Debt / Equity (Annual)0.46x
P/CF (TTM)20.27x
ROI (5Y Avg)5.22%
P/E Excl Extra (TTM)31.70x
LT Debt / Equity (Quarterly)0.46x
EPS Basic Excl Extra (TTM)$1.94
P/TBV (Quarterly)8.21x
P/B Ratio (Annual)5.83x
Dividend / Share (TTM)$0.00
Inventory Turnover (TTM)2.16x
Pretax Margin (TTM)16.86%
Book Value / Share (Annual)$16.34
Price vs S&P 500 (13W)-34.64%
Dividend Yield (TTM)0.00%
Beta0.69x
P/FCF (Annual)25.12x
Revenue / Share (TTM)$13.42
ROE (TTM)12.57%
52-Week Low$60.59
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.28
4.30
4.28
4.24
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
GMEDGLOBUS MEDICAL INC | 4.37x | 30.08% | 67.41% | 20.33% | $96.82 |
About
Boston Scientific manufactures minimally invasive medical devices for interventional procedures across cardiac rhythm management, interventional oncology, neuromodulation, and diagnostic imaging applications. The company serves healthcare institutions globally, with approximately 36% of revenues generated internationally.